PAM
AQST icon

Panagora Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Panagora Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-423
Closed -$2K – 1739
2021
Q2 		$2K Sell
423
-648
-61% -$2.59K ﹤0.01% 2618
2021
Q1 		$6K Hold
1,071
– – ﹤0.01% 2531
2020
Q4 		$6K Hold
1,071
– – ﹤0.01% 2406
2020
Q3 		$5K Buy
+1,071
New +$7K ﹤0.01% 2432

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LI
Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Panagora Asset Management's AQST Position: Q3 2021 in Review

Panagora Asset Management sold out of Aquestive Therapeutics (AQST) in Q3 2021, closing a stake of 423 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in AQST in Q3 2020 and held it in 4 quarters. The position peaked at $6K in Q1 2021. 46 funds tracked by Wall St. Rank hold AQST as of Q3 2021.

  • Panagora Asset Management reported no remaining Aquestive Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 423 Aquestive Therapeutics shares in Q3 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in Aquestive Therapeutics in Q3 2020 and held it in 4 quarters.
  • Panagora Asset Management's Aquestive Therapeutics position peaked at $6K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.